Ablacon Revenue and Competitors

Denver, CO USA

Location

$63.5M

Total Funding

Research

Industry

Estimated Revenue & Valuation

  • Ablacon's estimated annual revenue is currently $1.3M per year.(i)
  • Ablacon's estimated revenue per employee is $51,000
  • Ablacon's total funding is $63.5M.

Employee Data

  • Ablacon has 26 Employees.(i)
  • Ablacon grew their employee count by 18% last year.

Ablacon's People

NameTitleEmail/Phone
1
Chairman & CEOReveal Email/Phone
2
Founder, President & CSOReveal Email/Phone
3
VP FinanceReveal Email/Phone
4
Product OwnerReveal Email/Phone
5
Field Clinical EngineerReveal Email/Phone
6
Principal EngineerReveal Email/Phone
7
Lead Software ArchitectReveal Email/Phone
8
Software EngineerReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$100.8M7067%N/AN/A
#2
$17.3M154-10%N/AN/A
#3
$3.1M386%N/AN/A
#4
$3.1M389%N/AN/A
#5
$2.4M300%N/AN/A
#6
$0.2M40%N/AN/A
#7
$3.1M38-14%N/AN/A
#8
$161.8M1133-3%N/AN/A
#9
$65.8M602N/AN/AN/A
#10
$0.1M80%N/AN/A
Add Company

What Is Ablacon?

Atrial Fibrillation (AF) is the most frequent arrhythmic disorder of the heart. At Ablacon, we leverage our expertise in electrophysiology, computer vision and deep learning to build a real-time high-precision AI-based diagnosis system. We are an international team based in Lausanne (CH), Denver, CO (US) and Munich (DE) with a partner clinic in Hamburg (DE). If you are looking for the next big challenge, a wonderful team and a purpose that literally saves lives, you might want to consider joining us.

keywords:N/A

$63.5M

Total Funding

26

Number of Employees

$1.3M

Revenue (est)

18%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Ablacon News

2022-04-17 - Pulsed Field Ablation Treats AF With Few Complications

... Biosense Webster, Abbott, Ablacon, Acutus Medical, Affera, Apama Medical, Aquaheart, Atacor, Autonomix, Axon Therapeutics, Backbeat,...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$2.9M264%N/A
#2
$2.7M2735%N/A
#3
$3.8M274%N/A
#4
$5.7M280%N/A
#5
$4.1M2938%N/A